Management of acetaminophen toxicity l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 54

Management of Acetaminophen Toxicity PowerPoint PPT Presentation


  • 227 Views
  • Updated On :
  • Presentation posted in: General

Management of Acetaminophen Toxicity. History. Synthesized in 1877 in U.S. Extensive use began around 1947 Initially prescription only in the U.S. Otc status gained in 1960 toxic effects first noted in U.S. in 1971. It’s everywhere !. APAP is found in over 200 products

Download Presentation

Management of Acetaminophen Toxicity

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Management of acetaminophen toxicity l.jpg

Management of Acetaminophen Toxicity


History l.jpg

History

  • Synthesized in 1877 in U.S.

  • Extensive use began around 1947

  • Initially prescription only in the U.S.

  • Otc status gained in 1960

  • toxic effects first noted in U.S. in 1971


It s everywhere l.jpg

It’s everywhere!

  • APAP is found in over 200 products

    TylenolAnacin 3Tempra

    Tylenol coldGoody’sComtrex multi sx

    Contac Severe ColdJunior Strength TylenolVicks Nyquil

    Sinutab SinusTherafluSine-off

    SinarestRobitussin ColdPanadol

    Midol PMSSudafed SinusVanquish

    Vicks 44MUnisomSinglet

    PyrroxateMidol teenCoricidin

    Dimetapp allergyDrixoral ColdAlka Seltzer Plus

    Actifed SinusBenadryl allergyPanex


Actions l.jpg

Actions

  • Analgesia

    • Relieves mild to moderate pain

    • Efficacy equivalent to salicylates

    • Inhibits brain prostaglandin synthetase

    • Blocks pain impulses peripherally


Slide5 l.jpg

  • Antipyresis

    • Efficacy similar to salicylates

    • Inhibits prostaglandin synthetase in the

      hypothalamus


Slide6 l.jpg

In overdose situations, liver enzymes become saturated, glutathione is depleted, NAPQI

(N-acetyl-p-benzoquinoneimine)accumulates, and hepatic necrosis occurs


Pharmacokinetics l.jpg

Pharmacokinetics

  • Absorption

    • Rapidly absorbed from the GI tract

    • Peak concentration usually occurs between 60 and 120 minutes

    • Peak plasma levels almost always occur within 4 hours


Slide8 l.jpg

Distribution

  • Vd 1.0 - 2.0 L/Kg

  • Approximately 20% plasma protein bound

    may increase to 50% in overdose

  • Has been reported to cross the placenta


Slide9 l.jpg

Metabolism

  • Occurs via several pathways in the liver

    • 52% by sulfation

    • 42% by glucuronidation

    • 2% excreted unchanged in the urine

    • 4% biotransformed by C-P450 MFO system


Slide10 l.jpg

Excretion

  • APAP’s metabolic products are excreted by the kidneys

  • Minimal excretion into breast milk


Slide11 l.jpg

Half life

  • Average 2 hours

    • range 0.9 to 3.25 hours

  • No age related differences

  • No change in patients with renal disease

  • With liver dysfunction, may increase to 17 hours


  • Slide12 l.jpg

    Extracorporeal elimination

    • Hemodialysis

      • Not proven effective in reducing or preventing liver damage in overdose

    • Peritoneal dialysis

      • Not effective


    Toxicity l.jpg

    Toxicity

    • Factors involved in predicting hepatotoxicity

      • total quantity ingested

      • time from ingestion to treatment

      • age of the patient

      • alcoholism

      • enzyme inducing medications

      • serum concentration in relation to Rumack nomogram


    Slide14 l.jpg

    • Toxic dose

      • In adults, threshold for liver damage is 150 to 250 mg/kg

      • Children under 10 appear to be more resistant


    Slide15 l.jpg

    • Potential liver damage

      • Adults: > 150 mg/kg in acute dose

      • Adults: > 7.5 Grams in 24 hours (chronic)

      • Children (<10 yrs): > 200 mg/kg


    4 stages of acetaminophen poisoning l.jpg

    4 Stages of Acetaminophen Poisoning

    • Phase I (30 minutes to 4 hours)

      • Within a few hours after ingestion, patients experience anorexia, nausea, pallor, vomiting, and diaphoresis. Malaise may be present.

        Patient may appear normal


    Slide17 l.jpg

    • Phase II (24 to 48 hours)

      • Symptoms of Phase I are less severe. May seem like a period of recovery. Right upper quadrant pain may be present due to hepatic damage. Blood chemistry becomes abnormal with elevations of liver enzymes. Prothrombin times may be prolonged. Renal function may begin to deteriorate.


    Slide18 l.jpg

    • Phase III (3 to 5 days)

      • Characterized by symptoms of hepatic necrosis. Coagulation defects, jaundice, and renal failure have all been noted. Hepatic encephalopathy has been noted. Hepatic biopsy at this time would indicate centrilobular necrosis. Nausea and vomiting may reappear. Death is due to hepatic failure


    Slide19 l.jpg

    • Phase IV (4 days to 2 weeks)

      • Complete resolution or death


    Treatment l.jpg

    Treatment

    • GI decontamination

      • Syrup of Ipecac

        • return usually 30-40% at best

        • best if used early (first 1-2 hours)

      • Gastric lavage

        • effectiveness diminishes with time


    Slide21 l.jpg

    • Activated charcoal

      • Should not be witheld

      • dose 50-100 Grams

    • Cathartic

      • utilized to speed transit time


    Slide22 l.jpg

    • Hemodialysis

      • Limited benefit

      • Damage occurs quickly

    • Hemoperfusion

      • No benefit

    • Peritoneal dialysis

      • No benefit


    Blood sample l.jpg

    Blood Sample

    • 4hour post ingestion APAP level

      • levels drawn earlier may be erroneous

      • levels may be accurate out to 18 hours


    Slide24 l.jpg

    • Plot level on Rumack-Matthews nomogram

      • 150mg/dl at 4hours is possibly toxic

      • Do not use therapeutic “normal” values to determine potential toxicity!


    Slide25 l.jpg

    • Baseline CBC

    • creatinine, BUN, blood sugar, electrolytes

    • prothrombin times

    • AST, ALT

      • repeat q 24 hours

      • elevations typically seen 24-36 hours post ingestion


    Slide26 l.jpg

    Rumack and Matthew Nomogram

    150

    500

    Late

    100

    Not valid after 24 hours

    50

    10

    5

    mcg/ml4 8 12 16 20 24

    Hours After Acetaminophen Ingestion


    Slide27 l.jpg

    • If APAP level plots above the possible risk line administer N-acetylcysteine (NAC).

    • If NAC is indicated, full regimen should be followed. Do not stop NAC early if nomogram indicates toxic possibility


    N acetylcysteine nac l.jpg

    N-acetylcysteine (NAC)

    • Mechanism of action

      • glutathione substitute

      • may supply inorganic sulfur, altering metabolism

    • Route of administration

      • Orally or IV

        • IV not approved in the U.S.


    Slide29 l.jpg

    • NAC dosing

      • Oral 72 hour protocol

        • Loading dose is 140 mg/kg

        • Maintenance doses: 70 mg/kg

          • Given every 4 hours x 17 doses starting 4 hours after loading dose


    Slide30 l.jpg

    • NAC supplied as 10 or 20% oral solution

      • dilute to 5% final concentration with juice or soft drink

      • May be administered via NG tube

      • If emesis occurs within 1 hour of administration, repeat the dose


    Slide31 l.jpg

    • If emesis persists, antiemetics may be used

      • Reglan® (metoclopramide)

        • 0.1 to 1.0 mg/kg iv is often effective

      • If emesis is refractory, may consider

        Zofran® (ondansetron) or Kytril® (granisetron)

        • Expensive, but very effective


    Pediatric overdoses l.jpg

    Pediatric overdoses

    • More resistant to toxicity vs. adults

      • if a child plots in the possible risk category on the Rumack nomogram, do not resist using NAC because of this greater tolerance to APAP

      • Administer full course of NAC if nomogram indicates that it is needed


    Special considerations with nac l.jpg

    Special considerations with NAC

    • NAC administered on basis of nomogram plot

    • if initial level indicates need for NAC donot discontinue

    • subsequent APAP levels of interest only

    • If NAC begun before APAP level obtained, may DC NAC if level plots subtoxic on nomogram


    Nac side effects l.jpg

    NAC side effects

    • Relatively free of side effects when given orally

    • Emesis may occur

      • extremely offensive sulfur odor


    Slide35 l.jpg

    ED Admission

    Estimate time of ingestion

    Less than 4 hours since overdose 4 or more hours since overdose

    Less than 2 hours More than 2 hours since overdose since overdose

    Gastric emptying Activated charcoal

    Activated charcoal

    Draw blood plasma 4 hours after overdose for

    plasma acetaminophen assay

    Draw blood ASAP for plasma

    acetaminophen assay

    Acetaminophen concentration available Acetaminophen concentration not

    within 8 hours of overdose available within 8 hours of overdose

    Wait for acetaminophen assay result Start NAC pending assay result

    Loading does: 140 mg/kg

    APAP level below risk line on nomogram APAP level on or above risk line

    DC NAC if started Treat with full course of NAC

    No further medical management needed Daily LFT’s, prothrombin times

    Treat other med or psychiatric problems Provide supportive care


    Summary l.jpg

    Summary

    In overdose, APAP may overwhelm the liver stores of glutathione. A rise in liver enzymes may occur, which reflects the hepatic toxicity which may ensue. Timely administration of NAC may protect the patient from hepatic damage. Therapy should be initiated as soon as possible, but NAC is beneficial at any time. If APAP levels can not be obtained, assume a toxic dose has been ingested, initiate NAC, and continue until regimen complete.


    Case studies l.jpg

    Case Studies

    Case 1

    A 32 year old female presents to the ED 30 minutes after taking 31 Tylenol Extra Strength caplets in an apparent suicide attempt. She weighs 134 pounds, ambulated into the ED, is in no obvious distress, has had no symptoms prior to arrival.


    Signs symptoms l.jpg

    Signs/symptoms

    • Patient is awake and alert

    • HEENT: normal

    • No GI distress

    • PERRLA

    • Temp 98.7°F

    • HR 84, BP 128/76, R 19


    Lab results l.jpg

    Lab results

    • APAP pending

    • Salicylate pending

    • Tox screen Negative


    Calculations l.jpg

    Calculations

    • Patient weighs 60.9 kilograms

    • 15,500 mg of APAP ingested

    • mg/kg = 254

      • a potentially toxic “acute” dose


    Treatment41 l.jpg

    Treatment

    • Lavage

    • Activated charcoal

    • Cathartic

      • Hold NAC until APAP level results obtained

        • can get APAP level back within 2 hours


    Outcome l.jpg

    Outcome

    • APAP level 56 mg/dl drawn 4 hours post ingestion

    • ASA level 0

    • patient discharged asx to mental health unit

      7 hours after arrival


    Slide43 l.jpg

    Case 2

    A 25 year old male is brought to the ED by his girlfriend. She states that he has taken 24 “Tylenol” tablets. She brought the bottle with her and in fact the product is “Tylenol ER”. He ingested the caplets approximately 5 hours ago.


    Slide44 l.jpg

    Tylenol ER is a relatively new product which throws a curve into the traditional management of APAP overdoses. This product releases 325 mg of APAP immediately and 325 mg over the next 8 hours.


    Slide46 l.jpg

    Tylenol “ER” is referred to by poison center staff as

    TylenolEmergency Room


    Slide47 l.jpg

    • Unsure if nomogram is useful with this product

    • 1 case demonstrated to have biphasic peaks


    Signs symptoms48 l.jpg

    Signs/symptoms

    • Patient has vomited x 6 prior to arrival

    • Complaining of GI discomfort

    • HEENT: normal

    • PEERLA

    • Temp 98.9°F

    • HR 80, BP 130/78, R 20


    Slide49 l.jpg

    Labs

    • APAP level 110 mcg/ml at 5.0 hours post ingestion

    • ASA level 0

    • Tox screen negative for other substances


    Calculations50 l.jpg

    Calculations

    • Patient weighs 85 kilograms

    • 11,050 mg APAP was ingested

    • 183 mg/kg APAP ingested

      • Potentially toxic amount in acute od


    Treatment51 l.jpg

    Treatment

    • Activated charcoal with sorbitol given

    • Repeat APAP level 4 hours past the 1st level

    • Strongly consider NAC with this level

      • Initial 4 hour level > 100 start NAC


    Outcome52 l.jpg

    Outcome

    • Patient was treated with full course NAC

    • Liver enzymes were AST 220 U/L, and ALT 388 U/L at 27 hours post ingestion.

    • Liver enzymes returned to normal ranges within 72 hours.

    • Patient recovered uneventfully


    Points to remember l.jpg

    Points to remember

    • APAP is present in many poly drug overdoses

    • No symptoms may be present…screen

    • 150 mcg/ml at 4 hours is a “treat” level

    • NAC loading dose is 140 mg/kg

    • NAC maintenance doses are 70 mg/kg

    • Once NAC is started, DO NOT DC

    • Metoclopramide 0.1-1.0 mg/kg is very effective in controlling nausea/vomiting associated with APAP toxicity


    Slide54 l.jpg

    The End


  • Login